Goldman Sachs
IDIX

Goldman Sachs’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Goldman Sachs’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-250,000
Closed -$1.3M – 6949
2013
Q3 		$1.3M Sell
250,000
-50,000
-17% -$219K ﹤0.01% 4354
2013
Q2 		$1.08M Buy
+300,000
New +$1.23M ﹤0.01% 4335

Goldman Sachs's IDIX Position: Q3 2014 in Review

Goldman Sachs sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 602,888 shares — an estimated $14.5M sold.

Goldman Sachs first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $14.5M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Goldman Sachs reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Goldman Sachs sold 602,888 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $14.5M.
  • Goldman Sachs first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Goldman Sachs's IDENIX PHARMACEUTICALS INC position peaked at $14.5M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Goldman Sachs's 13F filing for Q3 2014, filed 14 Nov 2014.